Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Emergent Biosolutions
(NY:
EBS
)
9.530
+0.030 (+0.32%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Emergent Biosolutions
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment
August 18, 2022
Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments.
Via
Benzinga
WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant
August 18, 2022
Via
Benzinga
A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring
August 17, 2022
Blue Water Vaccines Inc (NASDAQ: BWV)
Via
Benzinga
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher
August 17, 2022
These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up.
Via
InvestorPlace
FDA Issues Warning Letter For Emergent Bio's Manufacturing Facility
August 15, 2022
Via
Benzinga
Merck Partner Joins Forces With Emergent Bio To Increase Access To Ebola Treatment
July 08, 2022
Via
Benzinga
The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand
August 17, 2022
Bavarian Nordic A/S (OTC: BVNKF), the only company with an approved vaccine for monkeypox, said it’s no longer sure it can meet demand as cases continue to rise worldwide,
Via
Benzinga
WeTrade's Monkeypox Testing Kits May Go Global. Why A New Agreement Is Sending Shares Soaring Double Digits?
August 16, 2022
Via
Benzinga
Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus
August 02, 2022
Via
Benzinga
Avis Budget, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday
August 02, 2022
FAT Brands Inc. (NASDAQ: FATBB) fell 30% to $10.50. The company recently posted a Q2 net loss of $8.2 million or $0.50 per share.
Via
Benzinga
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
August 03, 2022
Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
Via
Benzinga
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
August 02, 2022
Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Via
Benzinga
Recap: Emergent BioSolutions Q2 Earnings
August 01, 2022
Emergent BioSolutions (NYSE:EBS) reported its Q2 earnings results on Monday, August 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Monkeypox Stocks GOVX, VRAX, SIGA Rocket on Vaccine Shortage Fears
August 01, 2022
Monkeypox stocks are rallying today amid worries about a shortage of vaccines for the illness in the United States.
Via
InvestorPlace
Earnings Outlook For Emergent BioSolutions
July 29, 2022
Emergent BioSolutions (NYSE:EBS) is set to give its latest quarterly earnings report on Monday, 2022-08-01. Here's what investors need to know before the announcement. Analysts estimate that Emergent...
Via
Benzinga
Monkeypox Stocks SIGA, GOVX, BVNRY, CHMX, EBS Soar on Global Health Emergency
July 25, 2022
Drugs and vaccines used against smallpox are seen as the first line of defense against the rising tide of monkeypox infections.
Via
InvestorPlace
WWE, Infrastructure and Energy Alternatives And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
July 25, 2022
Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) shares rose 26% to $13.14 in pre-market trading. MasTec announced plans to acquire Infrastructure and Energy Alternatives for $14 per share...
Via
Benzinga
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
July 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For August 1, 2022
August 01, 2022
Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.
Via
Benzinga
Monkeypox Stocks BVNRY, EBS, CMRX, SIGA Heat Up on U.S. Vaccine Stockpile
June 29, 2022
Pharmaceutical companies that make vaccines against monkeypox are getting attention as demand for treatments against the virus grow.
Via
InvestorPlace
White House Outlines New Monkeypox Vaccine Strategy: What You Need To Know
June 29, 2022
Via
Benzinga
U.S. FDA Accepts Emergent's Anthrax Vaccine Candidate Filing For Review
June 24, 2022
The U.S. Food and Drug Administration (FDA) has accepted to review Emergent BioSolutions’ (NYSE: EBS) Biologics License Application (BLA) for its new anthrax vaccine candidate AV7909. The regulatory...
Via
Benzinga
7 Penny Stocks That Could Triple in 2022
June 22, 2022
Penny stocks are affordable and some with credible business models in all likelihood have the potential to generate superior returns.
Via
InvestorPlace
7 No-Brainer Biotech Stocks to Add to Your Buy List
June 09, 2022
With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile.
Via
InvestorPlace
7 Monkeypox Stocks That May Take Off in Q2
June 09, 2022
SIGA Technologies (SIGA) may lead on the list of Monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race.
Via
InvestorPlace
Morning Brief: Top Financial Stories Dominating on Tuesday, June 7
June 07, 2022
Reuters
Via
Benzinga
J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement
June 07, 2022
Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS).
Via
Benzinga
Emergent Bio Says Johnson & Johnson Breached COVID-19 Vaccine Contract
June 06, 2022
Emergent BioSolutions Inc (NYSE: EBS) said Johnson & Johnson (NYSE: JNJ) had breached an agreement by failing to buy the company's minimum quantity of COVID-19 vaccines.
Via
Benzinga
Monkeypox Outbreak Puts Focus On These Two Biotechs
May 27, 2022
Just when you thought it was safe to go outside, monkeypox pops up. Still, this might not be bad news for the market, as the world will turn once again to vaccine makers to find a solution.
Via
Talk Markets
7 Monkeypox Stocks to Watch Right Now
May 24, 2022
Wondering what are the best monkeypox stocks to watch? Here are the companies producing vaccines to help fight the spread of the virus.
Via
InvestorPlace
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.